The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Srebp-controlled glucose metabolism is essential for NK cell functional responses
Open accessAbstract
Activated natural killer (NK) cells engage in a robust metabolic response that is required for normal effector function. Using genetic, pharmacological and metabolic analyses, we demonstrated an essential role for Srebp transcription factors in cytokine-induced metabolic reprogramming of NK cells that was independent of their conventional role in the control of lipid synthesis. Srebp was required for elevated glycolysis and oxidative phosphorylation and promoted a distinct metabolic pathway configuration in which glucose was metabolized to cytosolic citrate via the citrate-malate shuttle. Preventing the activation of Srebp or direct inhibition of the citrate-malate shuttle inhibited production of interferon-γ and NK cell cytotoxicity. Thus, Srebp controls glucose metabolism in NK cells, and this Srebp-dependent regulation is critical for NK cell effector function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recently, it was demonstrated that the citrate–malate shuttle performs functions beyond that of an electron shuttle and, in fact, supports continuous citrate regeneration and TCA cycle intermediate homeostasis (119, 121).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [119]
Citations
Cites
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
Cheng, S.-C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H. A., Rao, N. A., Aghajanirefah, A., et al. (2014) · Science · doi:10.1126/science.1250684 · Cited by 2,224
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
Huang, S. C., Everts, B., Ivanova, Y., O’Sullivan, D., Nascimento, M., Smith, A. M., Beatty, W. L., Love-Gregory, L. D., Lam, W. Y., O’Neill, C. M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2956 · Cited by 1,256
Targeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,081
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
Arnold, M., Pandeya, N., Byrnes, G. B., Renehan, A. G., Stevens, G. A., Ezzati, M., Ferlay, J., Miranda, J. J., Romieu, I., Dikshit, R. P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71123-4 · Cited by 997
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Berod, L., Friedrich, C., Nandan, A., Freitag, J., Hagemann, S., Harmrolfs, K., Sandouk, A., Hesse, C., Castro, C. N., Bähre, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3704 · Cited by 927
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 375
MEF2C regulates NK cell effector functions through control of lipid metabolism
Li, J. H., Zhou, A., Lee, C. D., Shah, S. N., Ji, J. H., Senthilkumar, V., Padilla, E. T., Ball, A. B., Feng, Q., Bustillos, C. G., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01811-2 · Cited by 48
Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
Viel, S., Vivier, É., Walzer, T., & Marçais, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01098-w · Cited by 53
Natural Killer Cell Education Is Associated With a Distinct Glycolytic Profile
Pfeifer, C., Highton, A. J., Peine, S., Sauter, J., Schmidt, A. H., Bunders, M. J., Altfeld, M. A., & Körner, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03020 · Cited by 45
Natural Killer Cells: Friend or Foe in Metabolic Diseases?
Li, Y., Wang, F., İmani, S., Tao, L., Deng, Y., & Cai, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.614429 · Cited by 50
Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., & Xie, Z. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00689-6 · Cited by 52
Immunometabolism – The Role of Branched-Chain Amino Acids
Yahsi, B., & Günaydın, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886822 · Cited by 51
Qian, Y., Huang, R., Li, S., Xie, R., Qian, B., Zhang, Z., Li, L., Wang, B., Tian, C., Yang, J., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.2a0419-117r · Cited by 46
Diverse Immunoregulatory Roles of Oxysterols—The Oxidized Cholesterol Metabolites
Choi, C., & Finlay, D. K. (2020) · Metabolites · doi:10.3390/metabo10100384 · Cited by 48
Self-citationImpact of immune cells on the hallmarks of cancer: A literature review
Costa, A. C., Santos, J., da Costa, R. M. G., & Medeiros, R. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103541 · Cited by 48
Devillier, R., Chrétien, A.-S., Pagliardini, T., Salem, N., Blaise, D., & Olive, D. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0920-198rr · Cited by 49
Natural killer cells: the immune frontline against circulating tumor cells
Masmoudi, D., Villalba, M., & Alix‐Panabières, C. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03375-x · Cited by 47
The immunosuppressive landscape in tumor microenvironment
Liu, W., Zhou, H., Lai, W., Hu, C., Xu, R., Gu, P., Luo, M., Zhang, R., & Li, G. (2024) · Immunologic Research · doi:10.1007/s12026-024-09483-8 · Cited by 44
Borde, S., & Matosevic, S. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.08.009 · Cited by 41
Liu, Z., Ding, M., Qiu, P., Pan, K., & Guo, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1200282 · Cited by 43
Role of the Sterol Regulatory Element Binding Protein Pathway in Tumorigenesis
Jiang, T., Zhang, G., & Lou, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01788 · Cited by 41
How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
Kumar, V. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1840567 · Cited by 39
Wei, Y., Ding, J., Li, J., Cai, S., Liu, S., Hong, L., Yin, T., Zhang, Y., & Diao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717014 · Cited by 40
Essential Minerals and Metabolic Adaptation of Immune Cells
Alghamdi, M. A., Gutierrez, J., & Komarnytsky, S. (2022) · Nutrients · doi:10.3390/nu15010123 · Cited by 44
Cellular metabolism hijacked by viruses for immunoevasion: potential antiviral targets
Li, J., Wang, Y., Deng, H., Su, L., & Qiu, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1228811 · Cited by 40
Natural killer cell metabolism
Kobayashi, T., & Mattarollo, S. R. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.11.021 · Cited by 37
Natural killer cells in sepsis: Underprivileged innate immune cells
Kumar, V. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.12.003 · Cited by 38
Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury
Huang, M., Cai, H., Han, B., Xia, Y., Kong, X., & Gu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.870038 · Cited by 38
Aghayev, T., Mazitova, A., Fang, J. R., Peshkova, I. O., Rausch, M. P., Hung, M., White, K., Masia, R., Titerina, E. K., Fatkhullina, A. R., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1628 · Cited by 38
Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer
Slattery, K., Yao, C.-H., Mylod, E., Scanlan, J., Scott, B., Crowley, J. P., McGowan, O., McManus, G., Brennan, M., O’Brien, K., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adr4795 · Cited by 37
Self-citationHong, C., Jeong, E. J., Boyiadzis, M. M., & Whiteside, T. L. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1800979 · Cited by 37
Functional and metabolic targeting of natural killer cells to solid tumors
Wang, J., & Matosevic, S. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00523-7 · Cited by 35
Succinate in innate immunity: linking metabolic reprogramming to immune modulation
Atallah, R., Gindlhuber, J., & Heinemann, Á. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1661948 · Cited by 41
Yang, D., Peng, M., Hou, Y., Qin, Y., Wan, X., Zhu, P., Liu, S., Yang, L., Zeng, H., Jin, T., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2714-7 · Cited by 36
Metabolic but not transcriptional regulation by PKM2 is important for natural killer cell responses
Walls, J. F., Subleski, J. J., Palmieri, E. M., Gonzalez-Cotto, M., Gardiner, C. M., McVicar, D. W., & Finlay, D. K. (2020) · eLife · doi:10.7554/elife.59166 · Cited by 35
Self-citationModulating NK cell metabolism for cancer immunotherapy
Terrén, I., Orrantia, A., Vitallé, J., Astarloa-Pando, G., Zenarruzabeitia, O., & Borrego, F. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.10.003 · Cited by 39
Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance
Traba, J., Sack, M. N., Waldmann, T. A., & Antón, O. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.657293 · Cited by 39
Wilhelm, C., Masouleh, S. K., & Kazakov, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01742 · Cited by 35
Maya, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511937 · Cited by 35
Mutually assured destruction: the cold war between viruses and natural killer cells
Ali, A., Gyurova, I. E., & Waggoner, S. N. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.02.005 · Cited by 34
Jiao, D., Sun, R., Ren, X., Wang, Y., Tian, P., Wang, Y., Yuan, D., Yue, X., Wu, Z., Li, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113211 · Cited by 36
De novo polyamine synthesis supports metabolic and functional responses in activated murine NK cells
O’Brien, K., Aßmann, N., O’Connor, É., Keane, C., Walls, J. F., Choi, C., Oefner, P. J., Gardiner, C. M., Dettmer, K., & Finlay, D. K. (2020) · European Journal of Immunology · doi:10.1002/eji.202048784 · Cited by 33
Self-citationDeng, M., Wu, D., Zhang, Y., Jin, Z., & Miao, J. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.04.013 · Cited by 33
Niu, N., Ye, J., Hu, Z., Zhang, J., & Wang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087076 · Cited by 34
Kedia-Mehta, N., Tobin, L. M., Zaiatz-Bittencourt, V., Pisarska, M. M., Barra, C. D., Choi, C., Elamin, E., O'Shea, D. B., Gardiner, C. M., Finlay, D. K., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005047 · Cited by 37
Self-citationTherapy-induced shaping of the glioblastoma microenvironment: Macrophages at play
Erbani, J. M., Boon, M., & Akkari, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.003 · Cited by 35
Dong, S., Li, W., Li, X., Wang, Z., Zhou, C., Shi, H., He, R., Chen, C., & Zhou, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1038650 · Cited by 33
Wu, G., Fan, X., Cheng, L., Chen, Z., Yi, Y., Liang, J., Huang, X., Yang, N., Yin, J., Guo, W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx6489 · Cited by 37
Mechanism of tumor cells escaping from immune surveillance of NK cells
Ge, Z., Wu, S., Zhang, Z., & Ding, S. (2020) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1742733 · Cited by 29
Ghosh, S., Dutta, R. K., Goswami, D., Ghatak, D., & De, R. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189471 · Cited by 31
Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance
Weng, C.-Y., Kao, C.-X., Chang, T., & Huang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031258 · Cited by 29
Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat
Afolabi, L. O., Bi, J., Li, X., Adeshakin, A. O., Adeshakin, F. O., Wu, H., Yan, D., Chen, L., & Wan, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701671 · Cited by 30
TIPE2 deletion improves the therapeutic potential of adoptively transferred NK cells
Bi, J., Huang, C. Y., Jin, X., Zheng, C., Huang, Y., Zheng, X., Tian, Z., & Sun, H. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006002 · Cited by 29
Determiners of cell fates: the tricarboxylic acid cycle versus the citrate-malate shuttle
Guo, D. S., He, H., Meng, Y., Luo, S., & Lu, Z. (2022) · Protein & Cell · doi:10.1093/procel/pwac026 · Cited by 28
Akrami, S., Tahmasebi, A., Moghadam, A. A., Ramezani, A., & Niazi, A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106529 · Cited by 28
Moinuddin, A., Poznanski, S. M., Portillo, A. L., Monteiro, J. K., & Ashkar, A. A. (2024) · Immunological Reviews · doi:10.1111/imr.13316 · Cited by 29
Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy
Marr, B., Jo, D., Jang, M., & Lee, S.-H. (2025) · Immune Network · doi:10.4110/in.2025.25.e17 · Cited by 30
Hu, S., Heng, H., Yang, F., Wang, M., Liu, G., Xiang, Y., & Miao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1735873 · Cited by 32
High Metabolic Function and Resilience of NKG2A-Educated NK Cells
Highton, A. J., Diercks, B., Möckl, F., Martrus, G., Sauter, J., Schmidt, A. H., Bunders, M. J., Körner, C., Guse, A. H., & Altfeld, M. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.559576 · Cited by 27
Dai, Z., & Liu, P. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02870-x · Cited by 28
Vuletić, A. M., Martinović, K. M., Miletić, N. T., Zoidakis, J., Castellvı́-Bel, S., & Cavic, M. R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.750022 · Cited by 26
Yang, S., Tan, H.-X., Lai, Z., Peng, H., Yang, H., Fu, Q., Wang, H., Li, D., & Li, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04639-x · Cited by 33
Immmunometabolism of systemic lupus erythematosus
Furment, M. M., & Perl, A. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.109939 · Cited by 28
Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?
Sayed, R. E., Haibe, Y., Amhaz, G., Bouferraa, Y., & Shamseddine, A. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042142 · Cited by 27
Metabolic features of innate lymphoid cells
Yu, H., Jacquelot, N., & Belz, G. T. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221140 · Cited by 31
Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma
Lehmann, J., Caduff, N., Krzywińska, E., Stierli, S., Salas-Bastos, A., Loos, B., Levesque, M. P., Dummer, R., Stockmann, C., Münz, C., et al. (2023) · Science Advances · doi:10.1126/sciadv.adc8825 · Cited by 27
Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
Gerthofer, V., Kreutz, M. P., Renner, K., Jachnik, B., Dettmer, K., Oefner, P. J., Riemenschneider, M. J., Proescholdt, M. A., Vollmann‐Zwerenz, A., Hau, P., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092586 · Cited by 28
Self-citationReliance on Cox10 and oxidative metabolism for antigen-specific NK cell expansion
Mah-Som, A. Y., Keppel, M. P., Tobin, J. M., Kolicheski, A., Saucier, N., Sexl, V., French, A. R., Wagner, J. A., Fehniger, T. A., & Cooper, M. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109209 · Cited by 27
Gastric cancer mesenchymal stem cells inhibit natural killer cell function by up-regulating FBP1
Han, F., Guo, S., Huang, C., Cui, L., Zhao, Y., Ma, J., Zhu, M., Chen, Z., Wang, M., Shen, B., et al. (2021) · Central European Journal of Immunology · doi:10.5114/ceji.2021.111753 · Cited by 26
Krug, A., Martinez-Turtos, A., & Verhoeyen, E. (2021) · Cancers · doi:10.3390/cancers14010183 · Cited by 28
Resting natural killer cell homeostasis relies on tryptophan/NAD+ metabolism and HIF‐1α
Pelletier, A., Nelius, E., Fan, Z., Khatchatourova, E., Alvarado-Diaz, A., He, J., Krzywińska, E., Sobecki, M., Nagarajan, S., Kerdiles, Y. M., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256156 · Cited by 27
Clement, D., Szabo, E. K., Krokeide, S. Z., Wiiger, M. T., Vincenti, M., Palacios, D., Chang, Y., Grimm, C. M., Patel, S., Stenmark, H., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300406 · Cited by 26
Sweet Killers: NK Cells Need Glycolysis to Kill Tumors
Isaacson, B., & Mandelboim, O. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.008 · Cited by 25
The Metabolic Basis of ILC Plasticity
Pelletier, A., & Stockmann, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.858051 · Cited by 27
Bahadoran, A., Bezavada, L., & Smallwood, H. S. (2020) · Immunological Reviews · doi:10.1111/imr.12851 · Cited by 26
Pivotal role of exogenous pyruvate in human natural killer cell metabolism
Coquillat, N. K., Picq, L., Hamond, A., Megy, P., Benezech, S., Drouillard, A., Lager-Lachaud, N., Cahoreau, E., Moreau, M., Fallone, L., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-024-01188-4 · Cited by 24
SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC
Ruiz, C. F., Montal, E. D., Haley, J. D., Bott, A. J., & Haley, J. D. (2020) · The FASEB Journal · doi:10.1096/fj.202000052r · Cited by 29
Sun, Z., Li, Y., Zhang, Z., Fu, Y., Han, X., Hu, Q., Ding, H., Shang, H., & Jiang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.854432 · Cited by 24
Yang, Y., Chen, L., Zheng, B., & Zhou, S. (2022) · Oncogene · doi:10.1038/s41388-022-02562-w · Cited by 27
Cholesterol metabolism in tumor immunity: Mechanisms and therapeutic opportunities for cancer
Guo, X., Zhu, B., Li, J., Guo, P., Niu, Y., Shi, J., Yokoyama, W., Huang, Q., & Shao, D. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116802 · Cited by 23
Natural Killer Cells in Immunotherapy: Are We Nearly There?
Bachiller, M., Battram, A. M., Pérez-Amill, L., & Martín-Antonio, B. (2020) · Cancers · doi:10.3390/cancers12113139 · Cited by 26
Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy
Dastmalchi, F., Deleyrolle, L. P., Karachi, A., Mitchell, D. A., & Rahman, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.691246 · Cited by 23
Interplay of Immunometabolism and Epithelial–Mesenchymal Transition in the Tumor Microenvironment
Chou, M.-Y., & Yang, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189878 · Cited by 23
Ren, Z., Yu, Y., Chen, C., Yang, D., Ding, T., Zhu, L., Deng, J., & Xu, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.807737 · Cited by 24
Natural products target glycolysis in liver disease
Li, S., Hao, L., & Hu, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1242955 · Cited by 22
Immunometabolism in atherosclerotic disorders
Fleetwood, A. J., Noonan, J. E., Gruta, N. L. L., Kallies, A., & Murphy, A. J. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00473-5 · Cited by 28
The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
Velichinskii, R. A., Streltsova, M. A., Kust, S. A., Sapozhnikov, A. M., & Kovalenko, E. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111385 · Cited by 23
Železnjak, J., Lisnić, V. J., Popović, B., Lisnić, B., Babić, M., Halenius, A., L’Hernault, A., Roviš, T. L., Hengel, H., Erhard, F., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20182213 · Cited by 21
Khan, T. J., Xu, X., Xie, X., Dai, X., Sun, P., Xie, Q., & Zhou, X. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44030081 · Cited by 21
Metabolic regulation of immune responses to cancer
Wißfeld, J., Werner, A., Yan, X., ten Bosch, N., & Cui, G. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0381 · Cited by 21
Wang, Y., Chen, S., Xiao, X., Yang, F., Wang, J., Zong, H., Gao, Y., Huang, C., Xu, X., Fang, M., et al. (2023) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbad021 · Cited by 21
Metabolic regulation of innate and adaptive lymphocyte effector responses
Joseph, A. M., Monticelli, L. A., & Sonnenberg, G. F. (2018) · Immunological Reviews · doi:10.1111/imr.12703 · Cited by 21
Artemisinin sensitizes tumor cells to NK cell-mediated cytolysis
Lu, Z. Z., Bi, J., & Wan, X. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.094 · Cited by 21
The mechanobiology of NK cells- ‘Forcing NK to Sense’ target cells
Wong, D. C. P., & Ding, J. L. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188860 · Cited by 20
Decoding the crosstalk between mevalonate metabolism and T cell function
Kennewick, K. T., & Bensinger, S. J. (2023) · Immunological Reviews · doi:10.1111/imr.13200 · Cited by 20
Transcriptional programing of T cell metabolism by STAT family transcription factors
Villarino, A. V. (2023) · European Journal of Immunology · doi:10.1002/eji.202048825 · Cited by 19
Berlin, C., Mauerer, B., Cauchy, P., Lünstedt, J., Sankowski, R., Marx, L., Feuerstein, R., Schaefer, L., Greten, F. R., Pesic, M. H., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci169576 · Cited by 21
Fanalli, S. L., da Silva, B. P. M., Gomes, J. D., Ciconello, F. N., de Almeida, V. V., Freitas, F. A. O., Moreira, G. C. M., Silva‐Vignato, B., Afonso, J., Reecy, J. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14069-1 · Cited by 19
Cui, M., Yi, X., Cao, Z., Zhu, D., & Wu, J. (2022) · Journal of Oncology · doi:10.1155/2022/4257359 · Cited by 20
127aa encoded by circSpdyA promotes FA synthesis and NK cell repression in breast cancers
Gao, X., Sun, Z., Liu, X., Luo, J., Liang, X., Wang, H., Zhou, J., Yang, C., Wang, T., & Li, J. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01396-1 · Cited by 18
New Insights into Behçet’s Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation
Santarsiero, A., Leccese, P., Convertini, P., Padula, A. A., Abriola, P., D’Angelo, S., Bisaccia, F., & Infantino, V. (2018) · Mediators of Inflammation · doi:10.1155/2018/1419352 · Cited by 18
Immunosurveillance of cancer cell stress
Lorenzo‐Herrero, S., Sordo‐Bahamonde, C., Gonzalez, S. R., & López‐Soto, A. (2019) · Cell Stress · doi:10.15698/cst2019.09.198 · Cited by 18
Lipid Metabolism in Tumor-Associated Natural Killer Cells
Chen, Y., & Sui, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_5 · Cited by 19
Elaraby, E., Malek, A. I., Abdullah, H. W., Elemam, N. M., Saber-Ayad, M. M., & Talaat, I. M. (2021) · Journal of Immunology Research · doi:10.1155/2021/9972927 · Cited by 19
Xie, J., Fan, L., Xiong, L., Chen, P., Wang, H., Chen, H., Zhao, J., Xu, Z., Geng, L., Xu, W., et al. (2021) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-021-00509-7 · Cited by 18
Immunometabolism: a new dimension in immunotherapy resistance
Xiao, C., Xiong, W., Xu, Y., Zou, J. P., Zeng, Y., Liu, J., Peng, Y., Hu, C., & Wu, F. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1012-z · Cited by 18
Metadata
- Authors
- Assmann, N., O'Brien, K. L., Donnelly, R. P., Dyck, L., Zaiatz-Bittencourt, V., Loftus, R. M., Heinrich, P., Oefner, P. J., Lynch, L., Gardiner, C. M., Dettmer, K., & Finlay, D. K.
- Affiliations
- Trinity College Dublin (IE)
- University of Regensburg (DE)
- Corresponding author
- Finlay, David K
- ORCID
- Venue
- Nature Immunology
- Published
- 2017-09-18
- Volume
- 18
- Issue
- 11
- Pages
- 1197-1206
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2755907400
- Cited by
- 375
- References
- 57
- Citations by year
- 2026: 35 · 2025: 54 · 2024: 37 · 2023: 44 · 2022: 53 · 2021: 57 · 2020: 45 · 2019: 25 · 2018: 21 · 2017: 4
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- natural killer cells, SREBP, glucose metabolism, metabolic reprogramming, glycolysis, oxidative phosphorylation, interferon-gamma, NK cell cytotoxicity, cytokine activation, antitumor immunity, viral infection
- MeSH terms
- Animals, Flow Cytometry, Glucose, Glycolysis, Humans, Killer Cells, Natural, Lipids, Oxidative Phosphorylation, Immunoblotting, T-Lymphocyte Subsets, Cytokines, Cell Proliferation, Sterol Regulatory Element Binding Protein 1, Sterol Regulatory Element Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review